approval · primary record
BICTEGRAVIR SODIUM
FDA · NDA · 2026-08-27
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-08-27 |
| Brand | BIXLENVO |
| Sponsor | GILEAD SCIENCES INC |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:09.200Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:BICTEGRAVIR SODIUM:2026-08-27
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.